SPRinhibitor 3 is an effective sepiapterin reductase inhibitor. SPRinhibitor 3 decreases neuropathic and inflammatory pain through a reduction of BH4 levels. SPRinhibitor 3 shows a high binding affinity to human SPR in a cell-free assay (IC50=74 nM) an
CSRM617 is a selective small molecule inhibitor of the transcription factor ONECUT2 (OC2, the main regulator of androgen receptor). The Kd in SPR analysis is 7.43 uM, which can directly bind to the OC2-HOX domain. CSRM617 induces apoptosis by cleaving the